SARS-CoV-2: insight in genome structure, pathogenesis and viral receptor binding analysis–an updated review

EA Bhat, N Sajjad, A Ali, FM Aldakheel… - International …, 2021 - Elsevier
The novel coronavirus disease (COVID-19) a global pandemic outbreak is an emerging new
virus accountable for respiratory illness caused by SARS-CoV-2, originated in Wuhan city …

[PDF][PDF] The viral, epidemiologic, clinical characteristics and potential therapy options for COVID-19: a review.

C Li, BH Xu - European Review for Medical & Pharmacological …, 2020 - europeanreview.org
Coronavirus Disease-2019 (COVID-19) caused by SARS-CoV-2 infection has rapidly
spread all over the world, in just two months. As of 27 March, globally, 509,164 cases …

SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development

M Kaur, A Sharma, S Kumar, G Singh… - International journal of …, 2021 - Elsevier
Abstract Globally, SARS-CoV-2 has emerged as threat to life and economy. Researchers
are trying to find a cure against this pathogen but without much success. Several attempts …

COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks

C Murugan, S Ramamoorthy, G Kuppuswamy… - International Journal of …, 2021 - Elsevier
Today, the world population is facing an existential threat by an invisible enemy known as
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) or COVID-19. It is highly …

Approaches towards fighting the COVID‑19 pandemic

SC Tsai, CC Lu, DT Bau, YJ Chiu… - International …, 2021 - spandidos-publications.com
Abstract The coronavirus disease 2019 (COVID‑19) outbreak, which has caused> 46
millions confirmed infections and> 1.2 million coronavirus related deaths, is one of the most …

Characteristics of the coronavirus disease 2019 and related therapeutic options

B Huang, R Ling, Y Cheng, J Wen, Y Dai… - … Therapy Methods & …, 2020 - cell.com
The coronavirus disease 2019 (COVID-19) is a new type of pneumonia caused by severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. COVID-19 is affecting …

SARS-CoV-2: An update on genomics, risk assessment, potential therapeutics and vaccine development

I Mehmood, M Ijaz, S Ahmad, T Ahmed, A Bari… - International Journal of …, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a great threat to public
health, being a causative pathogen of a deadly coronavirus disease (COVID-19). It has …

SARS-CoV-2: Pathogenesis, molecular targets and experimental models

G Kanimozhi, B Pradhapsingh… - Frontiers in …, 2021 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recent pandemic
outbreak threatening human beings worldwide. This novel coronavirus disease-19 (COVID …

[HTML][HTML] SARS-CoV-2: structure, biology, and structure-based therapeutics development

MY Wang, R Zhao, LJ Gao, XF Gao… - Frontiers in cellular …, 2020 - frontiersin.org
The pandemic of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has been posing great threats to the world in many aspects. Effective therapeutic and …

Coronavirus diseases 2019: current biological situation and potential therapeutic perspective

S Khan, H Tombuloglu, SE Hassanein… - European Journal of …, 2020 - Elsevier
Abstract Coronavirus Disease 2019 (COVID-19) caused by a Severe Acute Respiratory
Syndrome Coronavirus-2 (SARS-CoV-2) was first reported in Wuhan, China at the end of …